Document and Entity Information - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2022

Mar. 20, 2023

Jun. 30, 2022

Cover [Abstract]

Document Type

10-K

Amendment Flag

false

Document Period End Date

Dec. 31, 2022

Document Fiscal Year Focus

2022

Document Fiscal Period Focus

FY

Entity Registrant Name

Ventyx Biosciences, Inc.

Entity Central Index Key

0001851194

Current Fiscal Year End Date

--12-31

Entity Well-Known Seasoned Issuer

Yes

Entity Voluntary Filers

No

Entity Current Reporting Status

Yes

Entity Filer Category

Non-accelerated Filer

Entity Interactive Data Current

Yes

Entity Small Business

true

Entity Emerging Growth Company

true

Entity Ex Transition Period

false

Entity Shell Company

false

Entity File Number

001-40928

Entity Incorporation, State or Country Code

DE

Entity Tax Identification Number

83-2996852

Entity Address, Address Line One

662 Encinitas Blvd

Entity Address, Address Line Two

Suite 250

Entity Address, City or Town

Encinitas

Entity Address, State or Province

CA

Entity Address, Postal Zip Code

92024

City Area Code

760

Local Phone Number

593-4832

Document Annual Report

true

Document Transition Report

false

Entity Public Float

$ 384.8

Entity Common Stock, Shares Outstanding

58,214,115

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

VTYX

Security Exchange Name

NASDAQ

ICFR Auditor Attestation Flag

false

Documents Incorporated By Reference

Portions of the registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2022.

Auditor Firm ID

42

Auditor Name

Ernst & Young LLP

Auditor Location

San Diego, California